Switzerland Archives

News and Trends 13 Jul 2016

Europe’s most valuable Biotech just launched 2 new Trials

Within a week, Actelion has announced both Phase II and III trial studies for insomnia and hypertension in children. Even for Europe’s most valuable biotech, this is an impressive period. Actelion is to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomnia. The day before this, it also announced a […]

July 13, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 11 Jul 2016

After Genentech, Roche could acquire another American Billion-dollar Biotech

Roche is rumored to make a move on the California biotech BioMarin. Despite a slightly weakened pipeline, Roche appears undeterred and previous offers were predicted to be around $15Bn. As big as some of the other industry veterans, BioMarin was founded in the 90’s boom in Biotech in San Rafaele, California. The deal itself is entirely based on […]

July 11, 2016 - 2 minutesmins - By Dani Bancroft

morphosys thrombosis phaseI novartis hucal

News and Trends 4 Jul 2016

Novartis delivers German Biotech’s 12th Antibody to Clinics

MorphoSys keeps up its impressive productivity in feeding pipelines. Its 12th antibody in its Novartis collaboration has just reached clinical development. After presenting results for two of its wholly-owned candidates at ASCO 2016 (you can get an insider look into ASCO from the team), MorphoSys is receiving good news on the collaborations’ front. One of the […]

July 4, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 27 Jun 2016

CRISPR Therapeutics increases its Series B to a Massive €125M

Everyone wants to invest in CRISPR Therapeutics, it seems. The Basel and Cambridge, US biotech has raised more money for its ongoing Series B round, bringing the total to over €126M. The authorization for the first CRISPR trials have just arrived in the hands of the FDA, and this might have encouraged new investment. CRISPR Therapeutics […]

June 27, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 20 Jun 2016

Meet the Biotech successfully using Bacteria for Immuno-Oncology

Yes, the title may have surprised you, but it’s true. Vaximm is one of the few biotechs worldwide using bacteria to activate the immune system against cancer. I was really surprised about how elegant the technology is when I had a chat with the Executive Chairman Klaus Breiner at BioEquity in Copenhagen. Vaximm is based in Basel […]

June 20, 2016 - 4 minutesmins - By Philip Hemme

crispr therapeutics muscle stem cells anagenesis

News and Trends 10 Jun 2016

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

CRISPR Therapeutics has struck a deal with Anagenesis Biotechnologies, which has key technology for muscle stem cells. Together, they will tackle muscle disorders – including the rare disease Duchenne Muscular Dystrophy (DMD). CRISPR Therapeutics (Basel, Switzerland) is the European champion of gene editing for health applications, a field that promises to revolutionize therapies – even if […]

June 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

zurich biotech octapharma ehtz switzerland

News and Trends 7 Jun 2016

Zurich is not all about Money – here are 9 Biotechs proving it!

The biggest city in Switzerland, Zurich, is one of Europe’s top financial centers and home to the SIX Swiss Exchange (SWX). It’s also one of the most expensive cities in Europe to live in (as my Swiss colleague Claire could confirm). With so much money nearby, how does the local Biotech ecosystem looks like? The biggest Biotech/mid-size Pharma in […]

June 7, 2016 - 5 minutesmins - By Denise Neves Gameiro

numab intarcia antibodies implantable drug delivery

News and Trends 6 Jun 2016

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This collaboration could span the next generation of implantable drug delivery tech for diabetes, obesity and autoimmune diseases. Based in Wädenswill (near Zurich), Numab is developing antibody-based therapeutics. With its ultra-high throughput technology, it can find rare molecules with big therapeutic potential that are […]

June 6, 2016 - 2 minutesmins - By Denise Neves Gameiro

crispr therapeutics gene editing labiotech refresh philip hemme biotech roger novak

News and Trends 1 Jun 2016

CRISPR Thx’ Founder: “We have over $250M in the bank”

So begins our series of videos documenting our biotech conference premier – Labiotech Refresh. Here Philip spoke with Rodger Novak, the CEO and founder of CRISPR Therapeutics, which is leading the biotech front on Gene Editing in Europe. Having the CEO of CRISPR Therapeutics come and speak at our first event was really exciting for […]

June 1, 2016 - 2 minutesmins - By Dani Bancroft

roche diabetes senseonics fluorescent sensor

News and Trends 30 May 2016

Roche debuts new MedTech for needle-free management of Diabetes

Roche is making progress in its Diabetes Care unit. It has struck a deal with the MedTech company Senseonics to sell an implantable glucose sensor in some major European countries. The Diabetes Care division of Swiss big Pharma Roche has more than 35 years of experience, and its Accu-Check devices are one of best-selling diabetes management […]

May 30, 2016 - 2 minutesmins - By Denise Neves Gameiro

roche fda pd l1 checkpoint inhibitor atezolizumab

News and Trends 19 May 2016

FDA approves First ever antibody to target Cancer PD-L1

Roche has received market approval for atezolizumab to treat a common type of bladder cancer. It’s the 3rd checkpoint inhibitor on the market, and the first to target PD-L1. Immuno-oncology is a hype field that promises to revolutionize cancer treatment, with a lot of active research and big deals (like the €600M deal between argenx […]

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

novigenix colox clinical cancer research

News and Trends 9 May 2016

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

Novigenix has published a validation study of its molecular blood test (Colox) which can reliably detect colorectal cancer at an early stage. Is this the second-place diagnostic in the race for Colorectal cancer blood tests? Based in Lausanne (Switzerland), Novigenix is developing molecular diagnostics from a new generation of predictive gene expression profiles and tumor-derived protein markers (biomarkers). Novigenix first […]

May 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Switzerland

Europe’s most valuable Biotech just launched 2 new Trials

After Genentech, Roche could acquire another American Billion-dollar Biotech

Novartis delivers German Biotech’s 12th Antibody to Clinics

CRISPR Therapeutics increases its Series B to a Massive €125M

Meet the Biotech successfully using Bacteria for Immuno-Oncology

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Zurich is not all about Money – here are 9 Biotechs proving it!

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

CRISPR Thx’ Founder: “We have over $250M in the bank”

Roche debuts new MedTech for needle-free management of Diabetes

FDA approves First ever antibody to target Cancer PD-L1

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!